Hello, everyone, and how are you this morning? A balmy day is emerging here on the Pharmalot corporate campus, where the leaves are falling, the dogs are fertilizing the weeds and the short people are leaving for the school houses. We are, therefore, celebrating with that mandatory cup of stimulation - our flavor today is Rain Forest Nut - and will then dig into some interesting reading. We hope you have a great day and climb that mountain. Stay in touch...
Glaxo To Cut 60 Jobs In Quebec (InPharm)
Pressure Grows On Drugmakers To Reveal R&D Returns (Reuters)
Lilly Profit Drops On Higher Expenses (Bloomberg News)
Couple Crusades For FDA Fast Track Of Genentech Cancer Med (The Express)
SAC Faces SEC Probe Into J&J Takeover Of Cougar (Bloomberg News)
Lilly And Amylin's Byetta Approved For New Use (Bloomberg News)
More Than One In 10 Americans Takes Antidepressants (Reuters)
Quintiles Acquires VCG & Associates To Bolster Marketing (MedCity News)
Sri Lanka Creates Pharma Manufacturing Zone (Colombo Page)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr





